An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian. The findings, published in Science Translational Medicine, highlight the potential importance of these under-studied cells in breast cancer progression.
This article was originally published on MedicalXpress.com

